Charles River Laboratories International (CRL) Intangibles (2009 - 2026)
Charles River Laboratories International (CRL) posted Intangibles of $253.2 million for Q2 2026, up 1.68% on a QoQ basis from $249.0 million in Q1 2026, and down 57.98% year-over-year from $602.5 million in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Intangibles (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Intangibles for 18 years, with the latest figure at $253.2 million in Q2 2026.
- On a quarterly basis, Intangibles fell 57.98% year-over-year to $253.2 million in Q2 2026; TTM through Jun 2026 was $253.2 million, a 57.98% decrease from a year earlier, with the FY2025 full-year figure at $340.0 million, down 53.0% from the prior year.
- Intangibles was $253.2 million for Q2 2026 at Charles River Laboratories International, up from $249.0 million in the prior quarter.
- The five-year high for Intangibles was $1.0 billion in Q2 2022, with the low at $249.0 million in Q1 2026.
- Average Intangibles over 5 years is $745.3 million, with a median of $813.9 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Intangibles increased 28.15% in 2022, then tumbled 62.03% in 2026.
- Over 5 years, Intangibles stood at $955.3 million in 2022, then dropped by 9.55% to $864.1 million in 2023, then slipped by 16.28% to $723.4 million in 2024, then plunged by 53.0% to $340.0 million in 2025, then retreated by 25.54% to $253.2 million in 2026.
- The last three Intangibles figures came in at $253.2 million (Q2 2026), $249.0 million (Q1 2026), and $340.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 4.75 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 33.11 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.15 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 253.17 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 586.80 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 44.39 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.12 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 253.17 Mn |
| Mar 28, 2026 | 248.99 Mn |
| Dec 27, 2025 | 340.00 Mn |
| Sep 27, 2025 | 571.09 Mn |
| Jun 28, 2025 | 602.45 Mn |
| Mar 29, 2025 | 655.71 Mn |
| Dec 28, 2024 | 723.40 Mn |
| Sep 28, 2024 | 778.46 Mn |
| Jun 29, 2024 | 800.13 Mn |
| Mar 30, 2024 | 827.64 Mn |
| Dec 30, 2023 | 864.05 Mn |
| Sep 30, 2023 | 886.29 Mn |
| Jul 1, 2023 | 929.89 Mn |
| Apr 1, 2023 | 958.12 Mn |
| Dec 31, 2022 | 955.28 Mn |
| Sep 24, 2022 | 968.02 Mn |
| Jun 25, 2022 | 1.03 Bn |
| Mar 26, 2022 | 1.02 Bn |
| Dec 25, 2021 | 1.06 Bn |
| Sep 25, 2021 | 1.10 Bn |